Thursday, April 18, 2024
HomeFunding TX-based BrainCheck Secures $15Million in Funding

[Funding alert] TX-based BrainCheck Secures $15Million in Funding

TX-based BrainCheck Secures $15Million in Funding. The innovation, commercialization, and venture capital division of UPMC, called UPMC Enterprises, led this round along with Next Coast Ventures and S3 Ventures.

TX-based BrainCheck Secures $15Million in Funding. The innovation, commercialization, and venture capital division of UPMC, called UPMC Enterprises, led this round along with Next Coast Ventures and S3 Ventures.

In order to further bolster the company’s strategic leadership, Nicholas Shapiro, vice president of UPMC Enterprises, was appointed to the Board of Directors.

The money will increase BrainCheck’s commercial traction, foster innovation in its product line, strengthen the company’s clinical evidence base, and broaden its influence across the healthcare industry, including significant system integrations.

Read also – CA-based Synctera Secures an $18.6Million in Series A-1 Extension to its 2021 Series A Funding

This revelation comes after BrainCheck’s next-generation platform and 3-minute screening solution were just released. These tools enable clinicians to evaluate and keep track of patients’ cognitive ability at any time, from any location.

Kim Rodriguez, CEO of BrainCheck said, “We are laser focused on commercializing and scaling a digital cognitive assessment platform that is clinically robust, easy for patients and their caregivers to use, enables a simplified provider experience and improves access to the actionable information needed to intervene sooner and potentially combat cognitive decline, We thank our current and new investors for their continued support and look forward to deploying this capital to play an important role in revolutionizing cognitive care.”

Michael Smerklo, Co-Founder and Managing Partner of Next Coast Ventures said, “We believe in BrainCheck’s vision to pioneer a fundamental shift in how cognitive care is delivered, Dementia is projected to impact 14 million people in the United States and 152 million globally in the coming decades, underscoring the importance of proactive measures to address prevention, early detection, and effective management strategies.1,2”

BrainCheck’s clinically validated platform, which streamlines screening, evaluation, care planning, and monitoring, is the most comprehensive commercially accessible solution across the cognitive care continuum. It is trusted by hundreds of the nation’s most distinguished clinicians and specialists.

Nicholas Shapiro, Vice President, UPMC Enterprises said, “Our decision to invest in BrainCheck is fueled by a deep understanding of the pressing burden of cognitive impairment on health care and the exciting solutions on the horizon to advance the industry. I am honored to join BrainCheck’s Board of Directors and look forward to working collaboratively with the team to drive strategic initiatives and shape the future growth trajectory of the Company, BrainCheck’s solutions offer rapid, reliable resources to support accurate assessments, stratify individual risk, and deliver actionable insights that can help all stakeholders – patients, caregivers, providers, and risk-bearers.”

About BrainCheck

BrainCheck, a nonprofit organization founded in 2015 by neuroscientists and technologists Drs. David Eagleman and Yael Katz, uses interactive cognitive assessment and cognitive care planning technologies to lessen the human and financial costs associated with cognitive impairment and dementia.

Read also – CA-based MoeGo Secures $24Million in Series A Round Funding

The BrainCheck platform is used by hundreds of hospitals and clinical practices to assist thousands of patients live safer and better lives at home, reduce caregiver stress, and save trillions of dollars for health systems.

- Advertisement -
RELATED ARTICLES
- Advertisment -

Most Popular